QP73 |
QP73 : Degrader (PROTAC) of FTO
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| FTO |
|
|
Degrader (PROTAC)
up to 1 uM
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
Quantitative proteomic analysis was performed on NB4 cells treated with 300 nM QP73 and found FTO wa ...
Potency Cellular
In Vitro
FTO
Mode of Action: Degrader (PROTAC)
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.apsb.2024.07.016
In Vivo Validations
Mouse
Dose: 3 mg/kg
Route of delivery:
Intravenous
Plasma half life:
1.25 ± 0.07 h
Systemic clearance:
20.1 ± 3.9 mL/min/kg)
Cmax:
2996 ± 441 ng/mL
Area Under the Curve::
2532 ± 445 h × ng/mL
DOI Reference: 10.1016/j.apsb.2024.07.016
Dose: 5 mg/Kg
Route of delivery:
Intraperitoneal
Plasma half life:
0.50 h
Systemic clearance:
7.39 mL/min/Kg
Cmax:
578 ng/mL
Area Under the Curve::
3201 h*ng/mL
DOI Reference: 10.1016/j.apsb.2024.07.016
Dose: 30 mg/kg
Route of delivery:
Oral
Plasma half life:
0.50 h
Systemic clearance:
4.55 mL/min/Kg
Cmax:
49.1 ng/mL
Area Under the Curve::
200 h*ng/mL
DOI Reference: 10.1016/j.apsb.2024.07.016
Negative Control Compounds
canSAR7437543
Notes: NB4 cells were treated with QP73N for 48 h did not show any degradation. Effect of QP73N on cell viability in NB4 and MV4-11 cells showed the compound is not toxic.
Chemical Information
| Molecular Formula | C39H36ClFN6O6 |
| SMILEs | Cc1noc(C)c1-c1cc(F)c(Nc2ccccc2C(=O)N2CCC3(CC2)CC(Nc2ccc4c(c2)C(=O)N(C2CCC(=O)NC2=O)C4=O)C3)c(Cl)c1 |
| InChI | InChI=1S/C39H36ClFN6O6/c1-20-33(21(2)53-45-20)22-15-28(40)34(29(41)16-22)43-30-6-4-3-5-26(30)36(50)46-13-11-39(12-14-46)18-24(19-39)42-23-7-8-25-27(17-23)38(52)47(37(25)51)31-9-10-32(48)44-35(31)49/h3-8,15-17,24,31,42-43H,9-14,18-19H2,1-2H3,(H,44,48,49) |
| Molecular weight | 738.24 Da |
| AlogP | 6.392640000000006 |
| HBond acceptors | 12 |
| HBond donors | 3 |
| Atoms | 89 |